Home › Calculator › RGNX Dividend Calculator 2026
RGNX Dividend DRIP Calculator 2026
14.34% YieldHealthcareREGENXBIO Inc. · NASDAQ
Price: $13.95 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When RGNX pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your RGNX snowball 📈
$10,000 in RGNX → $94.3K in 10 years · $4,564.16/month
About REGENXBIO Inc. (RGNX) — Dividend Analysis 2026
REGENXBIO Inc. is a biotechnology company operating in the clinical stage, dedicated to developing gene therapy candidates. These therapies are designed to introduce genes into cells, aiming either to rectify genetic deficiencies or to stimulate the body's own cells to produce therapeutic proteins or antibodies to combat diseases. Central to its therapeutic development is the proprietary NAV Technology Platform, an adeno-associated virus-based gene delivery system. The company's primary investigational asset, RGX-314, is currently in Phase III clinical trials for treating wet age-related macular degeneration. Its pipeline also includes RGX-121 and RGX-111, both in Phase I/II trials for mucopolysaccharidosis type II and type I, respectively; RGX-181, which is in preclinical development for late-infantile neuronal ceroid lipofuscinosis type II disease; RGX-202, undergoing Phase I/II evaluation for Duchenne muscular dystrophy; and RGX-381, at the preclinical stage for addressing the ocular manifestations of CLN2 disease. In addition to its internal programs, REGENXBIO Inc. licenses its NAV Technology Platform to other biotech and pharmaceutical enterprises. It also maintains a collaborative and licensing agreement with Neurimmune AG for the advancement of innovative gene therapies. Founded in 2008, REGENXBIO Inc. maintains its headquarters in Rockville, Maryland.
Compare RGNX with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full RGNX DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open RGNX position with:
🌍 RGNX Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold RGNX.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 14.34% | 11.54% | $1,434 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 12.19% | 9.39% | $1,219 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 11.47% | 8.67% | $1,147 / yr |
| 🇬🇧 UK ISA | 0% | 14.34% | 11.54% | $1,434 / yr |
| 🇬🇧 UK Taxable | 8.75% | 13.09% | 10.29% | $1,309 / yr |
| 🇨🇦 TFSA | 0% | 14.34% | 11.54% | $1,434 / yr |
| 🇨🇦 CA Taxable | 25% | 10.75% | 7.95% | $1,076 / yr |
| 🇦🇺 Super (pension) | 15% | 12.19% | 9.39% | $1,219 / yr |
| 🇦🇺 AU Taxable | 30% | 10.04% | 7.24% | $1,004 / yr |
| 🇩🇪 DE Taxable | 26.375% | 10.56% | 7.76% | $1,056 / yr |
| 🇫🇷 FR Taxable | 30% | 10.04% | 7.24% | $1,004 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 RGNX Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 RGNX Dividend Payment Schedule
RGNX pays quarterly — 4 times per year. Next ex-div: TBD.
📊 RGNX vs Healthcare Benchmarks
How RGNX compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for RGNX sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ RGNX Insider Activity
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| A-Award | 2026-06-30 | 1,453 | $10.18 | $14.8K | ||
| A-Award | 2025-12-31 | 951 | $7.00 | $6.7K | ||
| F-InKind | 2026-07-01 | 6,818 | $13.09 | $89.2K | ||
| M-Exempt | 2026-07-02 | 2,161 | $7.86 | $17.0K | ||
| Sale | 2026-07-02 | 2,161 | $13.64 | $29.5K | ||
| M-Exempt | 2026-07-02 | 2,161 | $7.86 | $17.0K | ||
| M-Exempt | 2026-07-01 | 36,725 | $7.86 | $288.7K | ||
| Sale | 2026-07-01 | 36,725 | $12.86 | $472.3K | ||
| Sale | 2026-06-29 | 19,608 | $11.04 | $216.5K | ||
| M-Exempt | 2026-07-01 | 36,725 | $7.86 | $288.7K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst Price Target
Wall Street consensusAnalyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the RGNX dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
REGENXBIO Inc. (RGNX) is currently trading at $13.95, 69% below its 52-week high. The current dividend yield is 14.34% based on an annual payout of $2.00 per share.
RGNX (REGENXBIO Inc.) — 14.34% Dividend Yield Analysis
REGENXBIO Inc. (RGNX) is a healthcare stock currently trading at $13.95 with a dividend yield of 14.34%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
- Above-average yield (14.34%) may signal elevated risk — verify sustainability.
Auto-generated from live market data. For educational purposes only — not financial advice.
Latest RGNX News
LiveNews aggregated from public sources via Finnhub & RSS. For informational purposes only.